SynthesisCancer gene therapy2023

Long-term response to autologous anti-CD19 chimeric antigen receptor T cells in relapsed or refractory B cell acute lymphoblastic leukemia: a systematic review and meta-analysis.

Magdi Elsallab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.